Rafarma and Haifa Technopark Enter Talks for Joint Venture
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an...
Rafarma and Haifa Technopark Enter Talks for Joint Venture
Rafarma Embarks on Aggressive Global Partnerships Plan
Rafarma Signed an Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov
Rafarma Adds Prestigious New Board Chairman Ilia Shpurov
Rafarma Conducts Strategy Conference in Thailand for University and Hospital Joint Venture
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects
Rafarma - Biocogency Acquisition Progresses to Preparation of GAAP Financials
Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.